Nolan M. Priedigkeit

Nolan M. Priedigkeit

Oncology
450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Minimal Residual Disease via circulating tumor DNA Predicts Exceptional Response in HER2-Positive Metastatic Breast Cancer.

Minimal Residual Disease via circulating tumor DNA Predicts Exceptional Response in HER2-Positive Metastatic Breast Cancer.

Journal: medRxiv : the preprint server for health sciences
Published: July 30, 2026

Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.

Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2026

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Journal: BMC medicine
Published: December 13, 2025

Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study.

Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study.

Journal: ESMO open
Published: April 10, 2025

Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer.

Hope for Others: Research Results from the University of Pittsburgh Rapid Autopsy Program for Breast Cancer.

Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024

Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.

Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer.

Journal: Breast cancer research : BCR
Published: November 15, 2024

Correction: Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.

Correction: Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.

Journal: Cancer research
Published: October 22, 2024

Clinicogenomic Characterization of Inflammatory Breast Cancer.

Clinicogenomic Characterization of Inflammatory Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 02, 2024

Clinicogenomic characterization of inflammatory breast cancer.

Clinicogenomic characterization of inflammatory breast cancer.

Journal: bioRxiv : the preprint server for biology
Published: May 20, 2024

HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.

HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 27, 2022

Hrq1/RECQL4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.

Hrq1/RECQL4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.

Journal: PLoS genetics
Published: February 28, 2022

Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine.

Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 23, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026